These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Approach to the use of antimicrobial combinations. Saag MS Ala J Med Sci; 1985 Jan; 22(1):72-5. PubMed ID: 3883831 [No Abstract] [Full Text] [Related]
27. Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty. Garvin KL; Hinrichs SH; Urban JA Clin Orthop Relat Res; 1999 Dec; (369):110-23. PubMed ID: 10611866 [TBL] [Abstract][Full Text] [Related]
28. [Antimicrobial peptides: a new way to treat bacterial infections]. Igaz P Orv Hetil; 2001 Jan; 142(4):169-71. PubMed ID: 11232153 [TBL] [Abstract][Full Text] [Related]
29. [Antibacterial therapy and the prevention of acute pyelonephritis and its complications]. Ezdokian AS; Ukhin AV Urol Nefrol (Mosk); 1989; (1):70-4. PubMed ID: 2655255 [No Abstract] [Full Text] [Related]
30. Therapeutic strategies involving antimicrobial treatment of disseminated bacterial infection in small animals. Garvey MS; Aucoin DP J Am Vet Med Assoc; 1984 Nov; 185(10):1185-9. PubMed ID: 6392253 [No Abstract] [Full Text] [Related]
31. Essential characteristics of antibiotics for the treatment of seriously ill patients. Moellering RC Clin Ther; 1981; 4 Suppl A():1-7. PubMed ID: 7326692 [TBL] [Abstract][Full Text] [Related]
32. [Fosfomycin in urogenital infections. Experimental assumptions and clinical results]. Savoia D; Fontana G; Laudi M; Cauda F Minerva Med; 1978 Dec; 69(59):4087-91. PubMed ID: 740304 [No Abstract] [Full Text] [Related]
33. [Antibiotic interaction with surface-active substances (a review of the literature)]. Gudz' OV; Pis'ko GT Vrach Delo; 1983 Nov; (11):103-8. PubMed ID: 6362195 [No Abstract] [Full Text] [Related]
34. Acute otitis media: antimicrobial therapy in an era of resistant bacteria and sceptical meta-analysticians. Teele DW N Z Med J; 2000 Jul; 113(1113):284-6. PubMed ID: 10935569 [No Abstract] [Full Text] [Related]
35. Bacterial persistence in vivo: resistance or tolerance to antibiotics. Acar JF; Sabath LD Scand J Infect Dis Suppl; 1978; (14):86-91. PubMed ID: 360377 [TBL] [Abstract][Full Text] [Related]
36. Changes in microbial ecology by therapeutic use of aminoglycosides. Bauernfeind A; Hörl G; Mönch V Scand J Infect Dis Suppl; 1986; 49():106-14. PubMed ID: 3547617 [TBL] [Abstract][Full Text] [Related]
37. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias]. Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial drug therapy. Braude AI Major Probl Intern Med; 1976; 8():111-218. PubMed ID: 772325 [No Abstract] [Full Text] [Related]
39. Targeting non-multiplying organisms as a way to develop novel antimicrobials. Coates AR; Hu Y Trends Pharmacol Sci; 2008 Mar; 29(3):143-50. PubMed ID: 18262665 [TBL] [Abstract][Full Text] [Related]
40. [Progress in antibacterial therapy]. Dimitriu SM Rev Med Chir Soc Med Nat Iasi; 1988; Suppl():15-25. PubMed ID: 3075795 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]